Autres langues HLB Co., Ltd.

Actions

A028300

KR7028300002

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 18/04/2024			Varia. 5j.	Varia. 1 janv.
97 300 ^KRW	+4,40 %		+7,51 %	+91,91 %

21/03	HLB Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
2023	Les actions sud-coréennes en léger recul pour la deuxième journée sur la prise de bénéfices	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	01/04
HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8%	22/03
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 29.99999658 billion in funding from HLB Co., Ltd. and other investors	22/03
HLB Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
HLB Co., Ltd. announced that it has received KRW 60 billion in funding from a group of investors	08/03
HLB Co., Ltd. announced that it expects to receive KRW 60 billion in funding from a group of investors	04/03
Bank of Canada Holds Rates Steady; ECB Expected -2-	25/01
South Korean Shares Marginally Decline for Second Day on Profit-Booking	22/12
HLB Shareholders Endorse Transition to Main Bourse from KOSDAQ	22/12
BPH Energy Appoints HLB Mann Judd as Auditor; Shares Plunge 10%	22/11
Century Sunshine Group’s Auditor Resigns; Successor Named	17/11
Rare Earth Magnesium’s Auditor Steps Down; Successor Appointed	17/11
Jinhai International Gets New Auditor	14/11
HLB Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
HLB, Hong Leong Islamic Bank, Cagamas Conclude MYR300 Million Green Assests Deal	04/10/23
Spenda Halts Trade Pending Court Nod for Auditor Appointment	04/09/23
Hessische Landesbahn weiter auf Wachstumskurs	04/09/23
5E Resources Appoints New Auditors	01/09/23
Elevar Therapeutics, Inc. announced that it has received KRW 58.174676146 billion in funding from HLB Co., Ltd.	11/08/23
Elevar Therapeutics, Inc. announced that it expects to receive KRW 58.174676146 billion in funding from HLB Co., Ltd.	09/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues HLB Co., Ltd.

Actions

A028300

KR7028300002

Autres langues

Filtres